>Abituzumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYTKYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARFLGRGAMDYWGQGTSVTVSS
>Abituzumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTIKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTFPYTFGGGTKLEIK
>Afutuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGQGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARCVYDGSWFVYWGQGTLVTVSA
>Afutuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
>Alacizumab VH
EVKLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARIGENYYGSSYDAMDYWGQGTSVTVSS
>Alacizumab VL
DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQEPDGTIKRLIYATSSLVSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYASFPPTFGGGTKLEIK
>Alemtuzumab VH
DVMLVESGGGLVQPGGSLSLSCAASGFTFTDYYMSWVRQPPGKALEWLGFIRNKANGYTTEYSASVKGRFTISRDNSQSILYLQMNALRAEESATYYCARYGGTTVAAPFDYWGQGTTLTVSS
>Alemtuzumab VL
DIKLIQSQASLSASLGETVTLTCRASQNINSYLAWYQQKQGKSPKLLVYNTKTLAEGVPSRFSGSGSGTQFSLKINSLQTEDFGNYYCQQHYGSPRTFGGGTKLEIK
>Anrukinzumab VH
EVQLVESGGGLVKLGGSLKLSCAASGFTFSSYAMSWVRQTPGKRLEWVATISSGGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARSDGYYGGFAYWGQGTLVTVSA
>Anrukinzumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSLMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSRTDFTLTINPVEADDIATYYCQQSNEDPWTFGGGTKLEIK
>Atezolizumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSDYAMNWIRQAPTKGLEWVASISPSGGSTHYRDSVKGRFTIFRDVAKSTLYLQMDSLRSEDTATYYCARRNWGGFDYWGQGVMVTVSS
>Atezolizumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASFHYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNSYPYTFGGGTKLEIK
>Bapineuzumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQVPTKGLEWVTSISSGGDNTYYRDSVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCVRQDYYSGPLDYWGQGVMVTVSS
>Bapineuzumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGQSPKRLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDVGVYYCWQGTHFPRTFGGGTKLEIK
>Bemarituzumab VH
QVQLQQSGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDGYYVKRFAYWGQGTLVTVSA
>Bemarituzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSNAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPYTFGGGTKLEIK
>Benralizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREGIRYYGYDYAMDYWGQGTSVTVSS
>Benralizumab VL
DIQMTQTTSSLSASLGDRVTISCRASEDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK
>Bevacizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREAYYYGSSHWYFDVWGAGTTVTVSS
>Bevacizumab VL
DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSKLPWTFGGGTKLEIK
>Blosozumab VH
EVQLQQSGAELVRPGASVKLSCTASGFNIKDDYMHWVKQRPEQGLEWIGWSDPENGDTEYASKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCTTGVTTAYYFDYWGQGTTLTVSS
>Blosozumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNLQSEDLADYFCQQYSSYPWTFGGGTKLEIK
>Bococizumab VH
QVQLKQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLDWIGDISPGSGSTTSNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARERPLRSYAMDYWGQGTSVTVSS
>Bococizumab VL
DIVMTQSHKSMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPRTFGGGTKLEIK
>Brontictuzumab VH
QVQLKQSGAELMKPGASVKLSCKATGYTFTGYWIEWVKQRPGHGLEWIGEILPGSGRTNYNEKFKGKATFTADTSSTPAYMPLSSLTTEDSAIYYCARFGGNYGYYAMDYWGQGTSVTVSS
>Brontictuzumab VL
QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQQKPDQLFTGLIGGTNNRAPGVPARFSGSLIGGKAALTITGAQTEDEAIYFCALWYSNHWVFGGGTKLTVL
>Cabiralizumab VH
VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARESPYYSNLYAMDYWGQGTSVTVSS
>Cabiralizumab VL
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDNYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPPTFGGGTKLEIK
>Camrelizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYTMSWVRQTPEKRLEWVATISGGGGNTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTALYYCARQLYYGNYFDYWGQGTTLTVSS
>Camrelizumab VL
DIQMTQSPASQSASLGESVTITCLASQTIGTWLAWYQQKPGKSPQLLIYTATSLADGVPSRFSGSGSGTKFSFKISSLQAEDFVSYYCQQLYSTPWTFGGGTKLEIK
>Cantuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRKPYWYFDVWGAGTTVTVSS
>Cantuzumab VL
DIVMTQAAPSVPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQRPGQSPQLLIYRMSNLASGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCLQHLEYPFTFGGGTKLEIK
>Cergutuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYVDDFKGRFAFSMETSASTAYLQINNLKNEDMATYFCARSIDYYGYVEAMDYWGQGTSVTVSS
>Cergutuzumab VL
DIVMTQSQQFVSTSVGDRVSVTCKASQNVGTNVAWDQQKPGQAPKALMYSASYRYSGVPDRFTGSGSGTDFTLTISNGQSEDLAEYFCHQYNSYPLFTFGSGTKLEIK
>Certolizumab VH
VQRVESGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARGYGSVYYAMDYWGQGTSVTVSS
>Certolizumab VL
DIVMTQSQTSMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNIYPLTFGAGTKLELK
>Citatuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADDFKGRFAFSLEPSASTAYLQINNLNNEDTATCFCARSALRLPGDYWGQGTTLTVSS
>Citatuzumab VL
DIVMTQVASSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPRTFGGGTKLEIK
>Clivatuzumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGFGNYGFAYWGQGTLVTVSA
>Clivatuzumab VL
QIVLTQSPSIMSASPGEKVTLTCSASSSVSSSYLYWYQQKPGSSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAASYFCHQWSSYPYTFGGGTKLEIK
>Codrituzumab VH
VQLQQSGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGALDPETGGTAYNQKFKGKAILTADKSSSTAYMELRSLTSEDSAVYYCTRFYYGSSYDYWGQGTTLTVSS
>Codrituzumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPTFGGGTKLEIK
>Cofetuzumab VH
QVQLKQSGPEVVRPGVSVKISCKGSGYTFTDYAMHWVKQSHAKSLEWIGVISTYNGNTNYNQKFKGKATNTVDNSSSTDYMELARLTSEDSAINYCARDDSYFFFYALDYWGQGTSVTVSS
>Cofetuzumab VL
IVLTHSPASLPVSLGLRATISCSASESVDSYGKSFMHWYQQKPGQPPKLLIYRASNRESGVPARFSGSGSRTDFTLTINRVEADDVATYYCQQSNEDPWTFGGGTKLEIK
>Concizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARLGGYDERDAMDYWGQGTSVTVSS
>Concizumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLDSDGKTYLNWLLQRPGESPKLLIYLVSKLDSGVPDRFTGSGSGTDFTLKISRVEAEDLGVYYCLQATHFPQTFGGGTKLEIK
>Crenezumab VH
EVELVESGGGLVQPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLELVATINSNGGSTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCASGIYYGYYFDYWGQGTTLTVSS
>Crenezumab VL
DIVMTQSPLSLPVSLGDQASISCSSSQSLVYSNGDTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
>Crizanlizumab VH
QVQLQQSGPELVKPGALVKISCKASGYTFTSYDINWVKQRPGQGLEWIGWIYPGDGSTKYNEKFKGKATLTADKSSSTAYMQLSSLTSENSAVYFCARSGEYGNYGGAMDYWGQGTSVTVSS
>Crizanlizumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNENPYTFGGGTKLEIK
>Dacetuzumab VH
EVQGVESGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSHGKSLEWIGRVNPNNGGTSYNQKFKGKAILTVDKSSSTAYMELRSLTSEDSAVYYCAREGYYGWGQGTTLTVSS
>Dacetuzumab VL
DIVMTQTPLSLSVSLGDQVSISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYTVSNRFSGVPDSFSGSGSGTDFTLKISRVETEDLGVYFCSQSTHVPWTFGGGTKLEIK
>Daclizumab VH
QVQLQQSGAELAKPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSTGYTEYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGGGNYVFDYWGQGTTLTVSS
>Daclizumab VL
QIVLTQSPAIMSASPGEKVTMTCSASSSISYMHWYQQKPGTSPKRWIYDTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYPLTFGAGTKLELK
>Dalotuzumab VH
VQLQQSGPGLVKPSQSLSLTCSVTGYSITSGYYWNWIRQFPGNKLEWMGYISYDGSNNYNPSLKNRISITRDTSKNQFFLKLNSVTTEDTATYYCARSGRYVFFDYWGQGTTLTVSS
>Dalotuzumab VL
DIVMTQSPLSLPVSLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPWTFGGGTKLEIK
>Dapirolizumab VH
QVQLKESGPGLVQSSQTLSLTCTVSGFSLTNYHVSWVRQPPGKGLEWMGGIWGDGSTNYNSALKSRLSISNDTSKSQVFLKMNSLQTEDTATYYCARDRTTRYYVLDAWGQGASVTVSS
>Dapirolizumab VL
DIQMTQTTSSMSASLGDRVTISCRASEDISTYLHWYQQKPGRSVKLLIYDTSGLHSGVPSRFSGSGSGADYSLTISSLEPEDVATYYCLQYSKFPFTFGAGTKLEIK
>Demcizumab VH
VQLQQSGPELVKTGASVKISCKASGYSFTGYYMHWVKQSHGKSLEWIGYISCYNGATSYNQKFKGKATFTVDTSSSTAYMELSSLTSEDSAVYYCARGYDYDVGMDYWGQGTSVTVSS
>Demcizumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSKEVPWTFGGGTKLEIK
>Denintuzumab VH
QVQLQQSGPGILQPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKRYNPALKSRLTISKDTSSNQVFLKIASVDTADTATYYCARMGLDGYYSYYFDYWGQGTTLTVSS
>Denintuzumab VL
IVLTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDVATYYCFQGSGYPFTFGSGTKLEIK
>Dezamizumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARGDYDYGGYYFDYWGQGTTLTVSS
>Dezamizumab VL
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGAPLTFGAGTKLELK
>Domagrozumab VH
EVKLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCAKQDYGYAMDYWGQGTSVTVSS
>Domagrozumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPWTFGGGTKLEIK
>Duligotuzumab VH
EVMLVESGGGLVQPGGSLRLSCAASGFTFSDYYMYWVRQTPEKRLEWVATISDGGSYTYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARESMVTFRYAMDYWGQGTSVTVSS
>Duligotuzumab VL
DIVMTQSQKFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQSNSYPYTFGGGTKLEIK
>Eculizumab VH
QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARDYYGSSPNWYFDVWGAGTTVTVSS
>Eculizumab VL
DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
>Efalizumab VH
QVQLQQSGAELVRPGASVKLSCKASGYSFTSYWMNWVKQRPGQGLEWIGMIHPSDSETRLNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCARGIYYYGSSYFDYWGQGTTLTVSS
>Efalizumab VL
DVQITQSPSYLAASPGETITINCRASKTISKYLAWYQEKPGKTNKLLIYSGSTLQSGIPSRFSGSGSGTDFTLTISSLEPEDFAMYYCQQHNEYPLTFGAGTKLELK
>Elotuzumab VH
EVQLVESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYTPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCARPYGNYVGSYWYFDVWGAGTTVTVSS
>Elotuzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVGIAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPYTFGGGTKLEIK
>Emactuzumab VH
VQLQQSGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPDSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARDGRGLYFDVWGTGTTVTVSS
>Emactuzumab VL
NIVMIQSPKSMSMSVGERVTLSCKASENVGTYVSWYQQKPEQSPQLLIYAASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYSYPTFGGGTKLEIK
>Emibetuzumab VH
VQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARANWLDYWGQGTTLTVSS
>Emibetuzumab VL
ENVLTQSPAIMSASPGEKVTMTCRASSSVSSIYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYPLTFGGGTKLEIK
>Emicizumab VH
VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSPGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARRLSYGGYLDVWGTGTTVTVSS
>Emicizumab VL
DIQMNQSPSSLSASLGDTITITCHDSQNINVWLSWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSTYPLTFGAGTKLELK
>Enavatuzumab VH
EVQVVESGGGLVQPGGSMKLSCVASGFTFSSYWMSWVRQSPEKGLEWVAEIRLKSDNYATHYAESVKGKFTISRDDSKSRLYLQMNSLRAEDTGVYYCTTYYGNYDAMDYWGQGTSVTVSS
>Enavatuzumab VL
DIVLTQSPASLAVSLGQRVTISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPYTFGGGTKLEIK
>Enoblituzumab VH
EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSSTIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARGGRVIYYGSPMDYWGQGTSVTVSS
>Enoblituzumab VL
DIVMTQSQKFMSTSVGDRVSVTCKASQNVDTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYNSYPFTFGSGTKLEIK
>Enokizumab VH
QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARPDYYGSSYVSFDYWGQGTTLTVSS
>Enokizumab VL
DIVMTQSQIFMSTSVGDRVTVTCKASQNVATNVAWYQQKPGQSPKALIYSTSYRYSGVPNRFTGSGSGTDFTLTISNVQSEDLAEYFCQQYYSYPLTFGAGTKLELK
>Epratuzumab VH
VQLQQSGAELVRPGTSVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGVINPSDSYTNYKQKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARRDTTTFYWGQGTTLTVSS
>Epratuzumab VL
NIMMTQSPSSLAVSVGERVTMSCKSSQSVLYSSNHKNYLAWYQQKPGQSTKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSWTFGGGTKLEIK
>Etaracizumab VH
EVQRVESGGGLVKPGGSLKLSCAASGFAFSSYDMSWVRQTPEKRLEWVAYVSSGGGSTYYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHEDGSFAYWGQGTLVTVSA
>Etaracizumab VL
DIVLTQSTATLSVTPGDRVSLSCRASQSISNYLHWYHQKSGESPRLLIMYASQSISGIPSRFSGSGSGTDFTLTINSVETEDFGVYFCQQSGSWPLTFGGGTKLELK
>Farletuzumab VH
EVQLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHGDDYDPAWFAYWGQGTLVTVSA
>Farletuzumab VL
EIVLTQSPALMAASPGEKVTITCSVSSSISSSNLHWYQQKSETSPKPWIYGTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSYPLMYTFGGGTKLEIK
>Fibatuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYSNHEDFDYWGQGTTLTVSS
>Fibatuzumab VL
DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYANYPYTFGGGTKLEIK
>Ficlatuzumab VH
QVQLQQPGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARNYYGSSIFDYWGQGTTLTVSS
>Ficlatuzumab VL
NIVMTQSPKSMSMSVGERVTLSCKASENVGSYVSWYQQKTEQSPKLVIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYSYPYTFGGGTKLEIK
>Flotetuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARSLLLRFSWFAYWGQGTLVTVSA
>Flotetuzumab VL
DIVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
>Fontolizumab VH
QVQLKQPGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGLLGKPWFADWGQGTLVTVSA
>Fontolizumab VL
NIVMTQSPKSMSMSIGERVTLSCKASENVDTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQSYNYPFTFGSGTKLEIK
>Fremanezumab VH
EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAQIRLKSDNYATHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTAYYDYDLAWFAYWGQGTLVTVSA
>Fremanezumab VL
IVMTQSPKSMSMSVGERDSLICQSSKNVRTYVHWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATYFTLTISSVQAEDLADYHCRQSYSYPYTFGAGTKLEIK
>Galcanezumab VH
QVQLQQSGAELVRPGTSVKMSCKASGYTFTNYWIGWAKQRPGHGLEWIGDIYPGGGYTNYNEKFKGKATLTADKSSSTAYMQFSSLTSEDSAIYYCARLSDYDGGFDYWGQGTTLTVSS
>Galcanezumab VL
DIQMTQTTSSLSASVGDRVTISCRASKDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPPTFGGGTKLEIK
>Gatipotuzumab VH
EVQLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRLKSNNYATHYAESVKGRFTISRDDSKSSVYLQMNNLRAEDTGIYYCTRHYYGSSYFDYWGQGTTLTVSS
>Gatipotuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGGGTKLEIK
>Gemtuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDYNMHWVKQSPGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCADGNPWFAYWGQGTLVTVSA
>Gemtuzumab VL
DIVLTQSPATLAVSLGQRATISCRASESVDNYGIRFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPWTFGGGTKLEIK
>Gevokizumab VH
QVTLKESGPGILKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARRRYDGPWFAYWGQGTLVTVSA
>Gevokizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGKTLPWTFGGGTKLEIK
>Ibalizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCAREGGNYGAWFAYWGQGTLVTVSA
>Ibalizumab VL
DIVMTQSPSSLAVSVGEKVTMSCKSSQSLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYRTFGGGTKLEIK
>Idarucizumab VH
QVQLQQSGPGLVAPSQSLSITCTVSGFSLTSYGVDWVRQSPGKGLEWLGVIWGGGSTNYNSALKSRLSISKDNSKSQVYLKMNSLQTDDTAMYYCASSAYYSYYSYDPFAYWGQGTLVTVSA
>Idarucizumab VL
DVVMTQTPLTLSVTIGQPASISCKSSQSLLYTNGKTYLNWLLQRPGQSPKRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCLQSTHFPHTFGGGTKLEIK
>Ifabotuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYWITWVKQRPGQGLEWIGDIYPGSGSTNYNEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYYSNHEDFDYWGQGTTLTVSS
>Ifabotuzumab VL
DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYANYPYTFGGGTKLEIK
>Iladatuzumab VH
QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCAREVGIRLDYWGQGTLVTVSA
>Iladatuzumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYDGDSFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Imgatuzumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYSKYNQKFKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARLSDGYPYYYAMDYWGQGTSVTVSS
>Imgatuzumab VL
DIKMHQSPPSLYPSLGARVTITCKASQDINNYLSWYQQKPGESPKTLIYRTNRLIDGVPSRFSGSGSGQDYSLTISNLEYEDMGIYYCLQDNEFPPTFGGGTKLELK
>Inebilizumab VH
VQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARSGGITTVRDFDYWGQGTTLTVSS
>Inebilizumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDNFGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPFTFGSGTKLEIK
>Inotuzumab VH
EVQLQQSGTVLARPGASVKMSCKASGYTFTSYWMHWVKQRPGQGLEWIGAIYPGNSDTSYNQKFKGKAKLTAVTSTSTAYMELSSLTNEDSAVYYCTREGYGNYGAWFAYWGQGTLVTVSA
>Inotuzumab VL
DVVVTQTPLSLSVSFGDQVSISCRSSQSLANSYGNTFLSWYLHKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPFTFGSGTKLEIK
>Itolizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRDYDGSSDYFDYWGQGTTLTVSS
>Itolizumab VL
DIKMTQSPSSTYASLGARVTITCKASQDIKSYLSWYQQKPWKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTFGSGTKLEIK
>Ixekizumab VH
VQLQQSGPELVKPGASVKISCKASGYSFTDYNMNWVKQSPGKGLEWIGLINPNYGTTSYNQKFKGKATLTVDQSSSTAYMQLNSLTSEDSAVYYCARYDYDSTGWFAYWGQGTLVTVSA
>Ixekizumab VL
DIVLTQSTLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHLPFTFGSGTKLEIK
>Labetuzumab VH
EVQLQESGGGLVQPGGSLKLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYTPSLKDKFIISRDNAKNTLYLQMSKVRSEDTALYYCATLYDGFPWFAYWGQGTLVTVSA
>Labetuzumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYRTFGGGTKLEIK
>Lacnotuzumab VH
EVQLQESGPGLVKPSQSLSLTCTVTDYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARFDYDGYYYAMDYWGQGTSVTVSS
>Lacnotuzumab VL
DILLTQSPAILSVSPGERVSFSCRASQSIGTSIHWYQQKTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSNSWPTTFGGGTKLEIK
>Ladiratuzumab VH
EVQLQQSGAELVKPGASVKLSCTASGLNIKDYYMHWVKQRPEQGLEWIGWIDPENGDTEYAPKFQGKATMTADTSSNTAYLQLSSLTSEDTAVYYCNAQNYGYGAWFAYWGQGTLVTVSA
>Ladiratuzumab VL
DVLMTQTPPSLPVSLGDQASISCRSRQSLLHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISSVEAEDLGVYYCFQGSHVPYTFGGGTKLEIK
>Lambrolizumab VH
QVQLQQSGAELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGEINPSNGGTNFNEKFKSKATPTVDKSSSTAYMQLSSLTSEDSAVYFCARRDYRYDVGPFDYWGQGTTLTVSS
>Lambrolizumab VL
DIVLTQSPASLAVSLGQRATISCRASKSVSTSGYSYMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPLTFGGGTKLEIK
>Lampalizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGETTYADDFKGRFAFSLDTSASTAYLQINNLKNEDMATYSCEREDSCRLTGTAYWGQGTMVTVSA
>Lampalizumab VL
ETTVTQSPASLSMAIGEKVTIRCITSTDIDDDMNWYQQKPGEPPKLLISEGNTLRPGVPSRFSSSGYGTDFVFTIENMLSEDVADYYCLQSDSLPYTFGGGTKLEIK
>Landogrozumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSDYNMAWVRQAPKKGLEWVASITSSGGSTYYPDSVKGRFTISRDNAKNTLYLQMNSLRSEDTATYYCARLDYGFDYWGQGTLVTVSS
>Landogrozumab VL
ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYHFTFGSGTKLEIK
>Lebrikizumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARDGYYDPYAMDYWGQGTSVTVSS
>Lebrikizumab VL
IVMTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPRTFGGGTKLEIK
>Lifastuzumab VH
EVQLVESGGGVVQPGKSLKLSCAASGFSFSDSAMAWVRQSPKMGLEWVATIIYDGSHTFYRDSVQGRFIISRDNAKNTLYLQMDSLRSEETATYYCARHEGFYWYFDFWGPGTMVTVSS
>Lifastuzumab VL
QTPLSLPVSLGDQAAISCRSSLSLVHSSGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPLTFGAGTKLELK
>Ligelizumab VH
QVQLQQPGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARFSHYYGSSYDYFDYWGQGTTLTVSS
>Ligelizumab VL
DILLTQSPAILSVSPGERVSFSCRASQSIGTSIHWYQQKTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQSNSWPTTFGGGTKLEIK
>Lintuzumab VH
VQLQQSGAELVKPGASVKISCKASGYTFTDYNMHWVKQSHGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCARGRPKYGNYGYAMDYWGQGTSVTVSS
>Lintuzumab VL
DIVLTQSPASLAVSVGQRATITCRASESVDNYGISFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFSLNIHPMEEDDTAMYFCQQSKEVPWTFGGGTKLEIK
>Lorvotuzumab VH
EVQLVESGGGLVQPGGSRKLSCAASGFTFSSFGMHWVRQAPEKGLEWVAYISSGSSTIYYADTVKGRFTISRDNPKNTLFLQMTSLRSEDTAMYYCARSRKGDYAMDYWGQGTSVTVSS
>Lorvotuzumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSIVHSDGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPSTFGGGTKLEIK
>Lumretuzumab VH
QVQLQQSGAELVKPGASVKLSCKTSGFTFSSSYISWLKQKPGQSLEWIAWIYAGTGGTSYNQKFTGKAQLTVDTSSSTAYMQFSSLTTEDSAIYYCARHRDYYGSNYFDYWGQGTTLTVSS
>Lumretuzumab VL
DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQSDYSYPYTFGGGTKLEIK
>Lutikizumab VH
EVKLQESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEGVATISDGGSYTYYPDNVKGRFTISRDNAKNNLYLQMSHLKSEDTAMYYCARGGVTTVVKGYFDVWGTGTTVTVSS
>Lutikizumab VL
DIQMTQSPASLSASVGETVTITCRASGNIHNYLAWYQQKQGKSPQLLIYNAKTLADGVPSRFSGSGSGTQYSLKINSLQPEDFGIYYCQHFWSIPYTFGGGTKLEIK
>Matuzumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEINPSNGRTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCASVDYDYDGGYFDVWGAGTTVTVSS
>Matuzumab VL
IVLTQSPAILSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNIFTFGSGTKLEIK
>Mepolizumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVCLKMNSLQIDDPAMYYCARDAPLLLLRLDYWGQGTSVTVSS
>Mepolizumab VL
DIVMTQSPSSLSVSAGEKVTMSCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNVHSYPFTFGSGTKLEIK
>Milatuzumab VH
QLQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTCTGEPTYADDFKGRFAFSLETSASTAYLQLTNLKNEDTATYFCSRSRGKYWFAYWGQGTLVTVSA
>Milatuzumab VL
DIVLTQSPLSLPVSLGDQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPTFGGGTKLEIK
>Mirikizumab VH
VQLKQSGPELVKPGASVKVSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARNWDEAYWGQGTLVTVSA
>Mirikizumab VL
DIQMTQSPSSLSASLGGRVTITCKASDHINNWLAWYQQKPGNAPRLLISGATSLETGVPSRFSGSGSGKDYTLSITSLQTEDVATYYCQQYWSTPFTFGSGTKLEIK
>Mogamulizumab VH
EVQLVESGGDLVKPGGSLKLSCAASGFTFSSYGMSWVRQTPDKRLEWVATISSGGSYSYYPDSVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHEDGNFHFDYWGQGTTLTVSS
>Mogamulizumab VL
DVLMTQTPLSLPVSLGDQASISCRSSQNIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPWTFGGGTKLEIK
>Monalizumab VH
QVQLQQSGAELVRPGSSVKLSCKASGYTFTSYWMHWVKQRPIQGLEWIGNIDPSDSETHYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARGGYDYDPLYWYFDVWGTGTTVTVSS
>Monalizumab VL
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLIYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGTPRTFGGGTKLEIK
>Mosunetuzumab VH
QVQLQQSGAELVRPGASVKLSCKASGYTFTDYYINWVKQRPGQGLEWIARIYPGSGNTYYNEKFKGKATLTAEKSSSTAYMQLSSLTSEDSAVYFCARDAYSNYYFDYWGQGTTLTVSS
>Mosunetuzumab VL
DIVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSRTRKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCKQSYNLRTFGGGTKLEIK
>Motavizumab VH
QVTLKVSGPGILQPSQTLSLTCSFSGFSLSTFGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPALKSRLTISKDTSKNQVFLKIANGDTADTATYYCARIMILYGNWYFDVWGTGTTVTVSS
>Motavizumab VL
IVMTQSPAIMSASPGEKVTITCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCFQGSGYPFTFGSGTKLEIK
>Natalizumab VH
VQLQQSGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYAPKFQGKATITADTSSNTAYLQLSSLTSEDTAIYYCARTGYYGNYGGYAMDYWGQGTSVTVSS
>Natalizumab VL
DIQMTQSPSSLSASLGGKVTITCKTSQDINKYMAWYQHKPGKGPRLLIHYTSTLQPGIPSRFSGSGSGRDYSFSISNLEPEDIATYYCLQYDNLWTFGGGTKLEIK
>Nemolizumab VH
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYDCARDGYDYDGPYYLDYWGQGTTLTVSS
>Nemolizumab VL
DIQMTKSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKISSLQPEDFGSYYCQHHDDSPLTFGAGTKLELK
>Nimotuzumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSGDYDDDGRCFDYWGQGTTLTVSS
>Nimotuzumab VL
DVLMTQTPLSLPVSLGDQASISCRSSQNIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHVPWTFGGGTKLEIK
>Obinutuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGQGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMHLSSLTSVDSAVYFCARCVYDGSWFVYWGQGTLVTVSA
>Obinutuzumab VL
DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK
>Ocaratuzumab VH
QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARSTVVGRDWYFDVWGTGTTVTVSS
>Ocaratuzumab VL
QIVLSQSPAILSASPGEKATMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGIPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSSNPPTFGGGTKLEIK
>Ocrelizumab VH
QVQLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARNLYYSNRSYWYFDVWGTGTTVTVSS
>Ocrelizumab VL
QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSSNPPTFGGGTKLEIK
>Olendalizumab VH
VQLQQSGPELVKPGASVKISCKASGYTFTDYSMNWVKQSHGKSLEWIGDINPNTGGTSYNQKFKGKATLNVDKSSSTAYMELRSLTSEDSAVYYCARGSYDGYYVYYYAMDYWGQGTSVTVSS
>Olendalizumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLESGVPARFSGSGSRTDFTLTISPVEADDVATYYCQQSNEDPYTFGGGTKLEIK
>Omalizumab VH
EVQLQESGPGLVKPSQSLSLTCSVTGYSITSGYYWNWIRQFPGNKLEWMGYISYDGSNNYNPSLKNRISITRDTSKNQFFLKLNSVTTEDTATYYCARGSHYYGSRHWYFDVWGTGTTVTVSS
>Omalizumab VL
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQAPKLLIYAASNLDSGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSHEDPYTFGGGTKLEIK
>Onartuzumab VH
QVQLQQSGPELVRPGASVKMSCTASGYTFTSYWMHWVKQRPGQGLEWIGMIDPSNSETRLNQKFKDKATLNVDKSSNTAYMQLSSLTSEDSAVYYCATARATPLDYWGQGTTLTVSS
>Onartuzumab VL
DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQQYYSYPWTFGGGTKLEIK
>Oportuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKALKWMGWINTYTGESTYADDFKGRFAFSLEPSASTAYLQINNLNNEDTATCFCARSALRLPGDYWGQGTTLTVSS
>Oportuzumab VL
DIVMTQVASSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPRTFGGGTKLEIK
>Otlertuzumab VH
EVQLQQSGPELEKPGASVKISCKASGYSFTGYNMNWVKQSNGKSLEWIGNIDPYYGGTSYNQKFKGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCARSDGNPFDYWGQGTTLTVSS
>Otlertuzumab VL
DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYDTPWTFGGGTKLEIK
>Ozanezumab VH
QVQLQQSGTELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNINPSNGGTNYNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCELELGRTGYWGQGTTLTVSS
>Ozanezumab VL
DIVITQDELSNPVTSGESVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGSGSGTDFTLEISRVKAEDVGVYYCQQLVEYPLTFGAGTKLELK
>Palivizumab VH
QVTLKVSGPGLLKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDDDKYYNPSLKSQLTISKDTSRNQVFLKITSVDTADTATYYCARSMITTHWYFDVWGAGTTVTVSS
>Palivizumab VL
DIVLTQTPAIMSASPGEKVTMTCSASLSVSYMHWYQQKSSTSPKLWIYDTSKLASGVPGRFSGSGSGNSYSLTISSMEAEDVATYYCFQGSGYPFTFGSGTKLEIK
>Parsatuzumab VH
VQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAREDVYYDYDDYAMDYWGQGTSVTGSS
>Parsatuzumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHSNGITYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPLTFGAGTKLELK
>Pateclizumab VH
VQLKESGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARPTMITPWFAYWGQGTLVTVSA
>Pateclizumab VL
DIVITQSHKFMSTSVGDRVSITCKASQDVSSAVAWYQQKPGQSPKLLIYSASYLYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPWTFGGGTKLEIK
>Pembrolizumab VH
QVQLQQSGAELVKPGVSVKLSCKASGYTFTNYYMYWVKQRPGQDLEWIGEINPSNGGTNFNEKFKSKATPTVDKSSSTAYMQLSSLTSEDSAVYFCARRDYRYDVGPFDYWGQGTTLTVSS
>Pembrolizumab VL
DIVLTQSPASLAVSLGQRATISCRASKSVSTSGYSYMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPLTFGGGTKLEIK
>Perakizumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSDYYMYWVRQTPEKRLEWVATISDGGSYTYYPDSVKGRFTISRDNAKNNLYLQMSSLKSEDTAMYYCARDRDYGSSYGAMDYWGQGTSVTVSS
>Perakizumab VL
DIKMTQSPSSMYASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDRGIYYCLQYDEFPPYTFGGGTKLEIK
>Pertuzumab VH
EVQLQESGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYCARNYGSSFYFDYWGQGTTLTVSS
>Pertuzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQYYSYPYTFGGGTKLEIK
>Pidilizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYSGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCVRVGYNGTMDYWGQGTSVTVSS
>Pidilizumab VL
QIVLTQSPAIMSASPGEMVTITCSASSSVSYMHWFQQKPGTSPKLWIYRTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPLTFGAGTKLELK
>Pinatuzumab VH
VQLQESGPELVKPGASVKISCKASGYAFSSSWMNWVKQRPGKGLEWIGRIYPGDGDTNYNGKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYFCARDGSSYDWYFDVWGTGTTVTVSS
>Pinatuzumab VL
DVLMTQTPLSLPISLGDQASISCRSSQSIVHSNGNTYLEWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCFQGSHFPYTFGGGTKLEIK
>Pogalizumab VH
LQLKESGPELVEPGASMKMSCKASGYTFTDSYMKGVRQSHGKSLEWIGDIYPKNGDTFYNQKFKDKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVMGLRLYWYFDVWGAGTTVTVSS
>Pogalizumab VL
DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPPTFGGGTKLEIK
>Polatuzumab VH
QVQLQQPGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGEATFTADTSSNTAYMQLSSLTSEDSAVYYCAREVGIRLDYWGQGTLVTVSA
>Polatuzumab VL
DIVMTQSPASLAVSLGQRATISCKASQSVDYDGDSFMNWFQQKPGQPPKLLIYAASNQGSGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Prasinezumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQTPTKGLEWVASISTGGGNTYYRDSVKGRFTISRDNAKNTQYLQMDSLRSEDTATYYCARHGATEGIDYWGQGTLVTVSS
>Prasinezumab VL
DIVMSQSPSSLAVSVREKVTMSCKSSQTLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPLTFGAGTKLELK
>Quilizumab VH
EVQLVESGGGLVQPGGSLKLSCAASGFTFSDYGMAWVRQAPRKGPEWVAFISNLAYSIYYADTVTGRFTISRENAKNTLYLEMSSLRSEDTAMYYCARHNWDAMDYWGQGTSVTVSS
>Quilizumab VL
DVVMTQTPLSLPVSLGDQASISCRSSQSLVHNNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYYCSQNTYVPWTFGGGTKLEIK
>Ralpancizumab VH
QVQLQQSGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGEINPSNGRTNYNEKFKSKATMTVDKSSSTAYMQLSSLTSEDSAVYYCARSRPLVRLPDYAMDYWGQGTSVTVSS
>Ralpancizumab VL
DIVMTQSHKSMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIYSASYRYTGVPGRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPRTFGGGTKLEIK
>Ranibizumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVRQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREAYYYGSSHWYFDVWGAGTTVTVSS
>Ranibizumab VL
DIQMTQTTSSLSASLGDRVTISCSASQDISNYLNWYQQKPDGTVKLLIYFTSSLHSGVPSRFSGSGSGTDYFLTISNLEPEDIATYYCQQYSKLPWTFGGGTKLEIK
>Ravulizumab VH
QVQLQQSGAELMKPGASVKISCKATGYTFSSYWIEWVKQRPGHGLEWIGEILPGSGSTNYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARDYYGSSPNWYFDVWGAGTTVTVSS
>Ravulizumab VL
DIQMTQSPASLSASVGETVTITCGASENIYGALNWYQRKQGKSPQLLIYGATNLADGMSSRFSGSGSGRQYSLKISSLHPDDVATYYCQNVLNTPLTFGAGTKLELK
>Refanezumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRGINYYGSSQISSYYYAMDYWGQGTSVTVSS
>Refanezumab VL
NIMMTQSPSSLAVSAGEKVTISCKSSHSVLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCHQYLSSLTFGAGTKLELK
>Reslizumab VH
QVQLKESGPGLVQPSQTLSLTCTVSGLSLTSNSVSWIRQPPGKGLEWMGVIWSNGGTDYNSAIKSRLVISRDTSKSQVFLKMNSLQAEDTAMYFCARIYYGGYFDYWGQGVMVTVSS
>Reslizumab VL
DIVLTQSPSSMYSSLGERVTITCKASQGIKSYLSWFQQKPGKSPKTLISRANRLVDGVPSRFSGSGSGQDFSLTISSLDYEDVGIYYCQQYYDFPRTFGGGTKLEIK
>Risankizumab VH
QVQLQQSDAELVKPGASVKISCKVSGYTFTDHTIHWMKQRPEQGLEWIGYIYPRDGSTKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDYAVYFCAIPDSSGYAWFAYWGQGTLVTVSA
>Risankizumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVATAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCHQYSSYPYTFGGGTKLEIK
>Rivabazumab VH
EVQLVESGGGLVQPGRSLKLSCAASGFTFSNYGMAWVRQAPTKGLEWVATISYDGSSTYYRDSVKGRFTISRDNAKSTLYLQMNSLRSEDTATYYCTRDRRHIYYYSGDYYYVMDAWGQGASVTVSS
>Rivabazumab VL
DIQMTQSPASLSVSVGETVTITCRASENIDRKLAWYQQKQGKSPQLLIYAATNLSDGVPSRFSGSGSGTQYSLKINSLQSEDLGSYYCQQFWGTPYTFGGGTKLEIK
>Romosozumab VH
VQLQQSGPELVKPGASVKIPCKASGYTFTDYNMDWVKQSHGKSLEWIGDINPNNGGTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDTAVYYYARLGYDSSYEDWYFDVWGTGTTVTVSS
>Romosozumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGDTLPYTFGGGTKLEIK
>Rontalizumab VH
VQLQQSGPELVKPGASVKMSCKASGYTFTNYIMHWVKQKPGQGLEWIGYINPYNDGTKYNENFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCASWIEVRRFMDYWGQGTSVTVSS
>Rontalizumab VL
DIVLTQSPASLAVSLGQRATISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVQEEDTATYYCQHSWEIPRTFGGGTKLEIK
>Rosmantuzumab VH
QVQLQQSGPELVKPGASVKISCKASGYTFTDYYINWVKQRPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYFCATYYSNNFDYWGQGTTLTVSS
>Rosmantuzumab VL
DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDSYMNWYQQKPGQPPKLLIYAASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPLTFGAGTKLELK
>Rovalpituzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDMATYFCAREGDSTGPFDYWGQGTTLTVSS
>Rovalpituzumab VL
SIVMTQTPKFLLVSAGDRVTISCKASQSVSNDVAWYQQKPGQSPKLLIYYASNRYTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCQQDYSSPWTFGGGTKLEIK
>Ruplizumab VH
QVQLKQSGAELVKPGASVKLSCKASGYTFTSYYMYWVKQRPGQGLEWIGEINPSNGGTNFNEKFKSKATLTVDKSSSTAYMQLSSLTSEDSAVYYCTRSDYRYDVNAMDYWGQGTSVTVSS
>Ruplizumab VL
DIVLTQSPASLAVSLGLRATISCRASQSVSTSSYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLNIHPVEEEDTATYYCQHSWEIPPTFGGGTKLEIK
>Sacituzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARRGYGSSYWYFDVWGAGTTVTVSS
>Sacituzumab VL
DIVMTQSHKFMSTSVGDRVSITCKASQDVSIAVAWYQQKPGQSPKLLIYSASYRYTGVPDRFSGSGSGTDFTFTISSVQADDLAVYYCQQHYITPWTFGGGTKLEIK
>Samalizumab VH
VQLQQTGPELVKPGASVKISCKASGYSFTDYIMLWVKQSHGKSLEWIGNINPYYGSTSYNLKFKGKATLTVDKSSSTAYMQLNSLTSEDSAVYYCARSGRYEDYFDYWGQGTTLTVSS
>Samalizumab VL
DIQMTQSPSSLSASLGERVTITCKASQDINSYLSWFQQKPGKSPKTLIYRANRLVDGVPSRFSGSGSGQDYSLTISSLEYEDMGIYYCLQYDEFPYTFGGGTKLEIK
>Sapelizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS
>Sapelizumab VL
DIQMTQTTSSLSASLRDSVTISCSASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNRLPYTFGGGTKLEIK
>Satralizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS
>Satralizumab VL
DIQMTQTTSSLSASLRDSVTISCSASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNRLPYTFGGGTKLEIK
>Simtuzumab VH
VQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSTSTAYMQLSSLTSEDTAVYFCARNWENFDYWGQGSTLTVSS
>Simtuzumab VL
DIVMTQAAPSLPVTPGESVSISCRSSKSLLHSNGNTYLYWFLQKPGQSPQLLIYRMSNLASGVPDRFSGSGSGTAFTLRISRVEAEDVGVYYCMQHLEYPYTFGGGTKLEIK
>Sofituzumab VH
VQLKESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARWTGTYGDGLDYWGQGTTLTVSS
>Sofituzumab VL
DIQMTQSSSSLSVSLGGRVTITCKASDHINNWLAWYQQKPGNAPRLLISGATTLETGVPSRFSGSGSGEDYTLSIISLQTEDVATYYCQQYWTTPFTFGSGTKLEIK
>Solanezumab VH
VQLVESGGGLVQPGGSLRLSCAASGFTFSRYAMSWVRQAPGKGLEWVSAINSVGSSTYVVDSVKGRFTISRDNAKNTLYLQLSSLKTEDTAIYYCARGLGRVDYWGQGTQVTVS
>Solanezumab VL
VMTQSPLSLPVSLGDQTSISCRSSQSLVYSDGNAYLHWYLQKPGQSPELLIYTVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPWTFGGGTKLEIK
>Spartalizumab VH
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSGSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRGTTATGAYWGQGTLVTVSA
>Spartalizumab VL
DIVMTQSPSSLTVTPGEKVTLSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
>Suvizumab VH
QVQLQQSGAELVRPGTSVKISCKASGYTFTNYWLGWVKQRPGHGLEWIGDIYPGGGYTNYNEKFKGKATLTADTSSSTAYMQLSSLTSEDSAVYFCARGIYGNFYAMDYWGQGTSVTVSS
>Suvizumab VL
DIVMTQSPSSLSVSAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPWTFGGGTKLEIK
>Tadocizumab VH
QVQLKESGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARRDGNYGWFAYWGQGTLVTVSA
>Tadocizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDINNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK
>Talacotuzumab VH
VQLQQSGPELVKPGASVKMSCKASGYTFTDYYMKWVKQSHGKSLEWIGVINPNNGDTFYNQKFKGKATLTVDKSSSTAYMQLDSLTSEDSAVYYCARSSLLRPSWFAYWGQGTLVTVSA
>Talacotuzumab VL
DIVMTQSPSSLAVSAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPYTFGGGTKLEIK
>Tanezumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTGYGVNWVRQPPGKGLEWLGMIWGDGSTDYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTARYYCARGGYYYGSSYYFDYWGQGTTLTVSS
>Tanezumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISNNLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK
>Telisotuzumab VH
VQLQQSGPELVKPGASVKISCKTSGYTFTEYTMHWVKQSHGKSLEWIGGINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSEITTVFDYWGQGTTLTVSS
>Telisotuzumab VL
DIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFMHWYQQKPGQPPKLLIYRASNLESGIPARFSGSGSRTDFTLTINPVEADDVATYYCQQSKEDPLTFGAGTKLELK
>Teplizumab VH
QVQLQQSGAELARPGASVKMSCKASGYTFTSYTMHWVKQRPGQGLEWIGYINPSSGYTNYNQKFKDKATLTADKSSSTAYMQLSSLTSEDSAVYYCARYYDDYAMDYWGQGTSVTVSS
>Teplizumab VL
IVMTQSTSSLSVSAGEKVTITCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPFTFGSGTKLEIK
>Tibulizumab VH
QVQLQESGPGLVKPSETLSLTCAVSGGSFSGYYWGWIRQPPGKGLEWIGYISGSSGSTDYNPSLKSRVTISTDTSKNQFSLKLSSVTAADTAVYYCARSYYNIWTGYYTHFDYWGQGVLVTVSS
>Tibulizumab VL
QIVLTQSPATMSASPGEKVTLTCSASQSVSSRYLSWYQQKPGSSPKLRIYSTSNLASGVPARFSGSGSGTSYSLTISSMEAEDAASYFCHQWSNYPPRTFGGGTKLEIK
>Tigatuzumab VH
EVQLVESGGGLVKPGGSLKLSCAASGFTFSSYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMSSLRSEDTAMYYCARRGSTMITTDYWGQGTTLTVSS
>Tigatuzumab VL
DIVMTQSPKFMSTSVGDRVSITCKASQDVGTAVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYRTFGGGTKLEIK
>Tildrakizumab VH
QVQLQQSGPELVRPGASVKLSCKASGYIFITYWMNWVKQRPGQGLEWIGQIFPASGSTNYNEMFEGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYQGFAYWGQGTLVTVSA
>Tildrakizumab VL
DIQMTQSPASLSAFVGETVTITCRASENIYSYLVWYQQKQGKSPQFLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGIPFTFGSGTKLEIK
>Timigutuzumab VH
EVKLMESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARGGGDGYPFYAMDYWGQGTSVTVSS
>Timigutuzumab VL
DIMMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRCTGVPDRFTGSGSGTDFTFTINSVQAEDLAVYYCQQHYSTPPTFGGGTKLEIK
>Tislelizumab VH
QVQLKESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARAYGNYWYFDVWGAGTTVTVSS
>Tislelizumab VL
SIVMTQTPKFLLVSAGDRVTITCKASQSVSNDVAWYQQKPGQSPKLLIYYASNRYTGVPDRFTGSGYGTDFTFTISTVQAEDLAVYFCHQDYSSPYTFGGGTKLEIK
>Tocilizumab VH
EVQLQESGPGLVKPSQSLSLTCTVTGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSGARATSAMDYWGQGTSVTVSS
>Tocilizumab VL
DIQMTQTTSSLSASLGDRVTISCRASQDISSYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEIK
>Trastuzumab VH
EVKLMESGAELVKPGASVKLSCTASGFNIKDTYMHWVKQRPEQGLEWIGRIDPANGNTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCARGGGDGYPFYAMDYWGQGTSVTVSS
>Trastuzumab VL
DIMMTQSHKFMSTSVGDRVSITCKASQDVNTAVAWYQQKPGHSPKLLIYSASFRCTGVPDRFTGSGSGTDFTFTINSVQAEDLAVYYCQQHYSTPPTFGGGTKLEIK
>Tregalizumab VH
VQLVETGGGLVRPGNSLKLSCVTSGFTFSNYRMHWLRQPPGKRLEWIAVITVKSDNYGANYAESVKGRFTISRDDSKSSVYLQMNRLREEDTATYYCSRGGYRYDAGAWFAYWGQGTLVTVSA
>Tregalizumab VL
DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSYMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPWTFGGGTKLEIK
>Vandortuzumab VH
VQLKESGPGLVKPSQSLSLTCTVSGYSITSDYAWNWIRQFPGNKLEWMGYISYSGSTSYNPSLKSRISITRDTSKNQFFLQLNSVTTEDTATYYCARSRPYDYDGYYYAMDYWGQGTSVTVSS
>Vandortuzumab VL
DIVMTQSPSSLAMSVGQKVTMSCKSSQSLLYSSNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAVYYCQQYYSYPRTFGGGTKLEIK
>Vatelizumab VH
VQLQESGPGLVAPSQSLSITCTVSGFSLTSYGVHWVRQPPGKGLEWLGVIWAGGSTNYNSALMSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCARANDGYYADYYAMDYWGQGTSVTVSS
>Vatelizumab VL
TQSPAIMSASPGEKVTITCSAISSVNYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWGSNPLTFGAGTKLELK
>Vedolizumab VH
QVQLQQPGAELVKPGASVKLSCKASGYTFTSYWMQWVKQRPGQGLEWIGEIDPSDSYTNYNQKFKGKATLTVDTSSSTAYMQLSSLTSEDSAVYYCARGGYDGEDYAMDYWGQGTSVTVSS
>Vedolizumab VL
DVVVTQTPLSLPVSFGDQVSISCRSSQSLANSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISTIKPEDLGMYYCLQGTHQPYTFGGGTKLEIK
>Veltuzumab VH
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSAYYGSSGYWYFDVWGAGTTVTVSS
>Veltuzumab VL
IVLTQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGGGTKLEIK
>Visilizumab VH
QVQLQQSGAELAKPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGYINPSSGYTKYNQKFKDKATLTADKSSSTAYMQLSSLTYEDSAVYYCARSAYYDYDGFAYWGQGTLVTVSA
>Visilizumab VL
IVLTQTPSSLSASLGDRVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCQQWSSNPPTFGGGTKLEIK
>Vonlerolizumab VH
LQLKESGPELVEPGASMKMSCKASGYTFTDSYMKGVRQSHGKSLEWIGDIYPKNGDTFYNQKFKDKATLTVDRSSSTAYMQLDSLTSEDSAAHYCVMGLRLYWYFDVWGAGTTVTVSS
>Vonlerolizumab VL
DIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPPTFGGGTKLEIK
>Vorsetuzumab VH
QIQLVQSGPELKKPGETVKISCKASGYTFTNYGMNWVKQAPGKGLKWMGWINTYTGEPTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCARDVGYLYGMDYWGQGTSVTVSS
>Vorsetuzumab VL
DIVLTQSPDSLAVSLGQRATISCRASKSVSTSGYSYMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHSRELPWTFGGGTKLEIK
>Vunakizumab VH
VQVVESGAELVRPGASVTLSCKASGYTFTDYEMHWVKQTPVHGLEWIGAIDPGTGGTDYNQKFKGKAILTADKSSSPAYLELRSLTSEDSAVYYCTRYPTHYGSSPYAMDYWGQGTSVTVSS
>Vunakizumab VL
IVITQTTAIMSASPGEKVTITCRASSSVNYMYWYQQKSDASPKPWIYRTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPWTFGGGTKLEIK
>Zenocutuzumab VH
EVQLQQSGPELVKPGASVKISCKASGYTFTDYYMNWVKQSHGKSLEWIGDINPNNGGTSYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYYCARDYGSRSYWYFDVWGTGTTVTVSS
>Zenocutuzumab VL
IVLTQSPATLSVTPGDRVSLSCSASQSISSYLHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPPTFGAGTKLELK
